- Trials with a EudraCT protocol (8)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
8 result(s) found for: Allopregnanolone.
Displaying page 1 of 1.
| EudraCT Number: 2005-005565-10 | Sponsor Protocol Number: 05-4027 | Start Date*: 2006-01-31 |
| Sponsor Name:Uppsala University | ||
| Full Title: Allopregnanolone effects on short term memory | ||
| Medical condition: Healthy women 35-40 years of age | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: SE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2004-002540-94 | Sponsor Protocol Number: UNC4022 | Start Date*: 2004-11-25 |
| Sponsor Name:Norrlands university hospital | ||
| Full Title: Effects of allopregnanolone in women with PMDD, depression, PCOS och oral contraceptives | ||
| Medical condition: PMDD (premenstrual dysphoric disorder) includes depressed mood and anxiety but occurs only during the late phase of the menstrual cycle. Major depression are more common in women and especially pos... | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: SE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2005-000944-98 | Sponsor Protocol Number: UNC4024 | Start Date*: 2005-05-02 |
| Sponsor Name:Norlands University Hospital | ||
| Full Title: FARMAKOKINETISKA EGENSKAPER HOS ISOALLOPREGNANOLON OCH ANTAGONISM AV ALLOPREGNANOLONS SEDERINGS EFFEKT HOS KVINNOR. Pharmacokinetic properties of isoallopregnanolone and antagonism of allopregnano... | ||
| Medical condition: Premenstrual Dysphoric Disorder (PMDD) / Severe Premenstrual Syndrome (PMS) | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: SE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2016-001217-25 | Sponsor Protocol Number: 2016-001217-25 | Start Date*: 2016-09-07 |
| Sponsor Name:Uppsala University | ||
| Full Title: Emotion, Serotonin and Premenstrual Dysphoric Disorder (EmSeP) | ||
| Medical condition: Premenstrual Dysphoric Disorder | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: SE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2013-004444-31 | Sponsor Protocol Number: KWMP001 | Start Date*: 2015-01-09 |
| Sponsor Name: | ||
| Full Title: Effects and consequences for mother and child from treatment for depression A prospective randomized, placebo- controlled, trial with internet-based cognitive behavior therapy and sertraline or... | ||
| Medical condition: Prosepctive randomized two armed study to evaluate moderate depression during pregnancy treated with interbnetbased CBT and sertarline or placebo and longterm outcome in the children.Secondary obj... | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: SE (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2021-006773-38 | Sponsor Protocol Number: TSPOC5FOR2022 | Start Date*: 2022-11-29 |
| Sponsor Name:Medizinische Einrichtungen des Berzirks Oberpfalz | ||
| Full Title: TSPO ligands in the treatment of depression: proof-of-concept of efficacy and underlying mechanisms of action | ||
| Medical condition: Unipolar/bipolar depressive disorder | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: DE (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2015-002142-31 | Sponsor Protocol Number: 547-SSE-301 | Start Date*: 2016-11-16 | |||||||||||
| Sponsor Name:Sage Therapeutics | |||||||||||||
| Full Title: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SAGE-547 INJECTION IN THE TREATMENT OF SUBJECTS WITH SUPER-REFRACTORY STATUS EPILEPTICUS | |||||||||||||
| Medical condition: SUPER-REFRACTORY STATUS EPILEPTICUS (SRSE) | |||||||||||||
|
|||||||||||||
| Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) BE (Completed) SE (Completed) DK (Completed) ES (Completed) NL (Completed) FI (Completed) HU (Completed) AT (Completed) IT (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2021-001045-12 | Sponsor Protocol Number: APH205 | Start Date*: 2021-09-22 | |||||||||||
| Sponsor Name:Asarina Pharma ApS | |||||||||||||
| Full Title: A randomized, open-label, multicenter, phase 2 clinical trial to explore the safety and efficacy of sepranolone in pediatric and adult patients with Tourette Syndrome. | |||||||||||||
| Medical condition: Tourette Syndrome | |||||||||||||
|
|||||||||||||
| Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: DK (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
